The Dharma System for Complex Drug Development & Manufacturing

Dharma Biologics | Bengaluru, India

At Dharma Biologics, capabilities are not standalone services. They are interlocking systems designed to move complex molecules from concept to commercial reality without fragmentation, rework, or execution drift.

Most CDMOs present long lists of offerings. What matters more is whether those offerings are designed to work together under pressure—across development, scale-up, inspection, and real-world use. Dharma Biologics was built specifically for that kind of pressure.

We are not the largest CDMO in India or Asia. We are built to be the most precise, the most integrated, and the most reliable partner for complex programs where quality, delivery, and regulatory outcomes matter more than volume metrics.

A System, Not a Menu

Every capability at Dharma Biologics exists inside a unified execution framework. Drug substance decisions inform drug product design. Drug product behavior informs device selection. Device constraints shape formulation and fill-finish strategy. Quality and regulatory expectations are embedded from the first experiment—not layered on later.

This is what we mean when we say Order Is the Source.

Our capabilities are organized around how molecules actually succeed in the real world—not how services are traditionally categorized.

Drug Substance Capabilities

Engineering the Molecule for Manufacturability

Dharma Biologics provides integrated drug substance development and manufacturing designed to support both clinical and commercial programs with long-term durability.

Our drug substance capabilities include:

• Microbial Fermentation
  High-performance expression systems using E. coli and yeast, optimized for yield, purity, and scalability.
• Mammalian Cell Culture
  CHO and HEK platforms designed for monoclonal antibodies, recombinant proteins, and complex biologics.
• Cell Line & Strain Engineering
  Rational design and optimization to improve productivity, stability, and process robustness.
• Process Development & Optimization
  Upstream and downstream process design focused on control, reproducibility, and regulatory readiness.
• Scale-Up & Tech Transfer
  Structured transfer from development to manufacturing with explicit risk mapping and mitigation.
• cGMP Drug Substance Manufacturing
  Clinical and commercial production executed under global regulatory expectations.

These capabilities are designed to ensure that molecules are not only biologically effective, but manufacturable at scale.

Drug Product Capabilities

Where Formulation Meets Reality

Drug product development is where many programs fail—not because the science is weak, but because systems are not designed for delivery, stability, and inspection simultaneously.

Dharma Biologics specializes in complex parenteral drug products, including:

• Sterile Injectables
  Liquid and lyophilized formulations developed for robustness, not just stability.
• High-Potency & Complex Formulations
  Programs requiring enhanced containment, precision handling, and strict process control.
• Prefilled Syringes, Vials & Cartridges
  Primary container systems engineered for accuracy, compatibility, and downstream device integration.
• High-Concentration Biologics
  Formulations designed to manage viscosity, protein interactions, and deliverability constraints.
• Aseptic Fill-Finish (Isolator-Based)
  Modern isolator lines supporting consistent sterility assurance and reduced contamination risk.

Drug product decisions are always made with device, patient use, and lifecycle change in mind.

Drug–Device & Combination Product Capabilities

One System, Not Two Vendors

Combination products demand a fundamentally different execution model. Dharma Biologics develops drug–device products as single integrated systems, not stitched-together deliverables.

Our combination product capabilities include:

• Autoinjectors
  Integrated development supporting biologics and complex injectables for self-administration.
• Fixed & Variable Dose Pens
  Precision dosing systems designed for chronic and repeat-use therapies.
• Prefilled Systems
  Syringe and cartridge platforms engineered for device readiness and scale.
• Combination Product Development
  System-level integration of formulation, container, device, usability, and manufacturing.
• Device Assembly & Final Packaging
  Controlled assembly and packaging strategies aligned with regulatory and performance requirements.
• Global Combination Product Compliance
  Documentation and validation designed for FDA, EMA, MHRA, and CDSCO expectations.

This is one of Dharma’s defining strengths—and a primary reason sponsors choose us.

Biologics Platforms

Depth Across Modalities

Dharma Biologics supports a wide range of biologic modalities with platform depth rather than superficial breadth:

• Monoclonal antibodies
• Recombinant proteins
• Fusion proteins
• Enzymes and specialty biologics
• Biosimilars
• Next-generation biologic modalities

These platforms are supported by integrated analytics, formulation science, and scalable manufacturing.

Complex Injectables & Specialty Dosage Forms

Where Others Step Back

Dharma Biologics has deep experience with injectable programs that fall outside standard playbooks:

• Lyophilization cycle development
• Long-acting injectables
• Controlled-release formulations
• Suspension and emulsion injectables
• Difficult-to-formulate APIs

In addition, we offer oral and specialty dosage forms, including:

• Soft gelatin capsules
• Advanced softgel technologies
• High-load and modified-release softgels
• Integrated blister and bottle packaging

These capabilities are executed with the same discipline applied to parenteral systems.

Development & Scientific Services

Data That Holds Up Under Scrutiny

Our scientific capabilities support development decisions that are defensible, transferable, and inspection-ready:

• Formulation science
• Analytical development
• Method validation
• Stability studies
• Extractables & leachables
• Comparability and bridging studies

Science at Dharma Biologics exists to support execution—not to generate unused data.

Manufacturing at Every Stage

From First-in-Human to Commercial Scale

We support manufacturing across the full lifecycle:

• Clinical manufacturing
• Commercial manufacturing
• Dedicated and multi-product suites
• High-volume and high-complexity programs
• Global supply programs

Manufacturing is designed for continuity, not episodic success.

Quality & Compliance

Regulatory by Design

Quality systems at Dharma Biologics are embedded, not reactive:

• cGMP systems aligned to global expectations
• Regulatory readiness for FDA, EMA, MHRA, and CDSCO
• Continuous audit readiness
• Client and partner audit support
• Data integrity frameworks aligned with ALCOA+

Quality is treated as an operating system—not a department.

Programs, Partnerships & Network Execution

Beyond individual projects, Dharma Biologics supports:

• Virtual biotech programs
• Big pharma partnerships
• Lifecycle management strategies
• Rescue and recovery programs
• Long-term manufacturing relationships

Through the Dharma CDMO Network, we extend these capabilities while maintaining unified execution standards.

Why This Matters

Capabilities only matter if they compound.

At Dharma Biologics, every capability strengthens the others. The result is fewer handoffs, fewer surprises, and programs that move forward with clarity and confidence.

This is not about being everything to everyone.
It is about being the right system for complex work.

From Bengaluru, Built for the World

ಕ್ರಮವೇ ಮೂಲ.

Contact our team at info@dharmabiologics.com